Synthesis and characterization Some of heterocyclic compounds from Nitrogen derivative


Faculty of Education for Girls, University of Kufa, Iraq

Abstract

This paper involves the synthesis of new oxazepine derivatives by multi-reaction steps. The first step synthesis azo derivative from 2-naphthol with 3-aminoacetophenone. The second step was the condensation reaction between ketone group of the azo compound and different primary aromatic amines (4-amino phenol, 3-nitro aniline and 4-methyl aniline) to yiled new azo Schiff base compounds (S1-S3) respectively. In the final step, Oxazepine compounds (L1-L3)and (L4-L6)were prepared from reaction imine compounds (S1-S3) with maleic and phthalic anhydride in toluene as solvent. All these derivatives were characterized by melting point, FTIR, HNMR and 13CNMR.

Keywords

Azo compounds, multi-reaction steps, Schiff bases, Oxazepine

Introduction

The chemistry of heterocyclic compounds has been an interesting field of study (Verma, Gupta, & Yadav, 2015) for a long time due its more application in several fields such as medicinal, pharmaceutical and selective drugs (Mohammad, Ahmed, Mahmoud, & Ahmad, 2017) Oxazepine stands for unsaturated non-homologous seven associated heterocycle having Oxygen in position 1 and nitrogen in position 3 along with five carbon atoms (Abid & Ramadan, 2018). Oxazepine has three isomers bases on the location of oxygen and nitrogen atoms in the seventh ring (Abid, Tawfeeq, & Muslim, 2017).

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/ac20e6a6-253e-4c4f-a331-e5a24ebcc78f/image/7242faf8-1b29-414c-9f62-2746e954488d-uscheme1.png
Figure 1: Oxazepine with three isomers bases

It is organized through the Pericycliccyclo addition of Schiff bases with maleic and phthalic anhydrides (Ali & Ghanim, 2016). Oxazepine derivatives have a huge diversity of biological activities like antifungal (Taha, 2017), hypotic muscle relaxant (Kadhim, 2017), antibacterial (Choudhary et al., 2018) telomerase inhibitors (Mohammed, Ahmed, & Abachi, 2017), anti-inflammatory (Mohammad, Alsamarrai, & Mahmood, 2019) and antiepileptic (Jarallah, Nief, & Atia, 2019) (1,4)Oxazepine was taken up to designing potent progesterone receptor antagonists (Al-Lami & Salom, 2019). (1,4) Oxazepine is found to be a dynamic moiety in numerous psychoactive pharmaceuticals (Majeed, Mohsein, & Aldujaili, 2018).

Preparation Methods

The methods of chemical preparations are as below in details. Table 1 shows the physical features of organized compounds.

(1) Synthesis1-(3-((2-hydroxy naphthalene-1-yl)diazenyl)acetophenone

3-aminoacetophenone (0.03 mol, 4.05 gm) was dissolved in (3ml)of concentrated hydrochloric acid and (20 ml) of distilled water. The solution was cold at (0 co) in an ice-water bath. The sodium nitrite (0.03 mol, 2.07 gm)was dissolved in (10 ml) of distilled water and added dropwise to the solution with stirring .2- naphthol (0.03 mol, 4.32 gm) was dissolved in (20 ml) of ethanol and (10 ml) of sodium hydroxide 10% and cooled to (0Co), added to the diazonium solution is dropwise and stirring at (0Co)for (2h) for obtaining the coupling agent. The result of the orang gold compound was precipitated, filtered and washed with water.

(2)Synthesis of azo Schiff bases derivatives (S1-S3)

Ethanolic mixture (30 ml) containing 1 drop of concentrated hydrochloric acid to azo acetophenone derivative (A) of (0.003 mol, 1.0 gm)then adding (0.37gm, 0.47gm, 0.36 gm) of primary aromatic amines (4-amino phenol, 3-nitro aniline and 4- methyl aniline). The reaction mixture was refluxed with stirring for (10-35) hours at (78) Co, the reaction was completed and examined by using TLC (Methanol: dry benzene 1:4)recrystallized from ethanol.

(3)Synthesis of (L1-L3) Oxazepine and (L4-L6) Oxazepine

A mixture of azo-Schiff bases derivatives (S1-S3) (0.5gm, 0.3gm,0.3 gm) with (0.16 gm , 0.1 gm , 0.1gm) maleic anhydreid (0.25gm ,0.14gm ,0.11gm) phthalic anhydride respectively in (30 ml) of Tolouene , was refluxed for (19h, 6h ,33h) hours for compounds (L1-L3) and (19h,4h,32h) hours for compounds (L4-L6).

Table 1: Physical features of organized compounds

Yiled %

R.F

m.p

co

M.wt

g

m.f

Compound

No.

91

---

156-158

290.32

C18H14N2O2

A

87

0.9

162-164

381.44

C24H19N3O2

S1

81

0.9

160-162

410.43

C24H18N4O3

S2

87

0.7

174-176

379.46

C25H21N3O1

S3

70

0.9

108-110

481.51

C28H23N3O5

L1

93

0.8

136-138

510.51

C28H22N4O6

L2

90

0.9

105-106

479.54

C29H25N3O4

L3

63

0.9

116-118

529.55

C32H23N3O5

L4

79

0.8

130-132

558.55

C32H22N4O6

L5

88

0.9

111-113

527.58

C33H25N3O4

L6

Results and Discussion

The coupling reaction (Hamdan, Hamdan, & Ali, 2018) between diazonium salt with 2-naphthol to produce 1-(3((2-hydroxynaphthalen-1-yl)diazenyl) acetophenone. Azo-Schiff bases (S1-S3) were synthesized by condensation of the equimolar quantity of primary aromatic amines (4-amino phenol, 3-nitro aniline, 4-methal aniline) with azo acetophenone derivative (A). Apericyclic reaction (Nief, 2018) is one that occurs by a concerted process through a cyclic transition state. The word concerted means that all bonding changes occure simultaneously; no intermediates are involved (Khidir, Sulaiman, & Ismael, 2018). Pericyclic reaction represents an imperative type of concerted (solitary step) processes including π-systems (Sallal & Ghanem, 2018) A concerted rearrangement of the electrons that causes δ and π-bonds break and from to simultaneously (Taha, 2017). Apericyclic reaction between imine groups of azo-Schiff bases (S1-S3) as two membered compounds and cyclic acid oanhydride (maleic, phthalic anhydride)as five-membered compounds in Tluene were syntheized compounds (L1-L3) and (L4-L6) respectively (Choudhary et al., 2018). Figure 2 depicts the mechanism of synthesis of 1,3-Oxazepine.

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/ac20e6a6-253e-4c4f-a331-e5a24ebcc78f/image/a4b7c97b-3526-479a-94ed-c6315490e734-uscheme2.png
Figure 2: Mechanism of synthesis 1,3-Oxazepine

The structures of all synthesis compounds were depicted in Figure 3.

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/ac20e6a6-253e-4c4f-a331-e5a24ebcc78f/image/90099931-fd32-4a05-a40f-96e800f7e88f-uscheme3.png
Figure 3: Structures of each synthesized compounds

Spectral Characterization

Our derivative identified with variety spectral methods like (FT.IR, H.NMR, C13.NMR) spectra with microbial assay

FT.IR Spectra of Derivatives

The FT.IR Spectrums of derivatives are depicted in Figure 9; Figure 8; Figure 7; Figure 6; Figure 5; Figure 4.

A

S1max 1683.86 (C=N), 1502.55 (N=N) , 3061.03 -3030.17 (-CH,aromatic), 3414.00-3406.29(OH), 1618.28 (C=C) , 1355.96(CH3).

S2 max 1683.86 (C=N), 1500.62 (N=N) , 3066.82 -32972.31 (-CH,aromatic), 3458.37-3437.15 (OH), 1620.21 (C=C) , 1357.89 (CH3).

S3 max 1689.64 (C=N), 1581.63 (N=N), 3099.61 -3062.96 (-CH,aromatic), 3439.08-3360.00(OH), 1641.42 (C=C), 1355.96 (CH3).

L1 max 1712.79 (Lactone C=O), 1685.79-1658.78 (C=O ester and amide), 3061.03 to 2922. 16 (C-H,aromatic), 1600.92-1581.63 (C=C,aromatic ),1398.39 and 1361.74 (O-C-O and –N-C-), 1168.86 (C-O).

L2max 1718.58(Lactone C=O),1681.93 and 1624.06 (C=O ester and amide),3088.03 to 2922.16(C-H, aromatic), 1593.20-1519.91(C=C,aromatic).

L3 max 1712.79(Lactone C=O),1681.93 and 1618.28 (C=O ester and amide),3059.10 to 3028.24(C-H, aromatic), 1587.42-1556.55(C=C,aromatic).

L4 max 1712.79(Lactone C=O),1639.49 and 1616.35 (C=O ester and amide),3064.89 to 2987.74(C-H, aromatic), 1589.34(C=C,aromatic).

L5 max 1681(Lactone C=O),1618.28 (C=O ester and amide),3062.96 to 3018.60(C-H, aromatic), 1568.13-1552.70(C=C,aromatic).

L6 max 1720.50(Lactone C=O),1681.93 and 1618.28 (C=O ester and amide),3064.89 to 3014.74(C-H, aromatic), 1589.34-1568.13(C=C,aromatic.

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/ac20e6a6-253e-4c4f-a331-e5a24ebcc78f/image/1a8d8902-c8a8-47aa-985c-48f7ef1c7930-upicture1.png
https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/ac20e6a6-253e-4c4f-a331-e5a24ebcc78f/image/e5b7d146-f0cb-4dd4-9702-0849bece7814-upicture2.png
Figure 5: 1-((3-(1-((4-hydroxyphenyl)imino)ethyl)phenyl)diazenyl)naphthalen-2-ol(S1) and 1-((3-(1-(p-tolylimino)ethyl)phenyl)diazenyl)naphthalen-2-ol (S3)
https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/ac20e6a6-253e-4c4f-a331-e5a24ebcc78f/image/201a94aa-32cf-41d9-95e3-11af480c1964-upicture3.png
Figure 6: 2-(3-((2-hydroxynaphthalen-1-yl)diazenyl)phenyl)-3-(4-hydroxyphenyl)-2-methyl-1,3-oxazepane-4,7-dione(L1) and3-(3-((2-hydroxynaphthalen-1-yl)diazenyl)phenyl)-3-methyl-4-(3-nitrophenyl)-3,4-dihydrobenzo[e][1,3]oxazepine-1,5-dione (L5)
https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/ac20e6a6-253e-4c4f-a331-e5a24ebcc78f/image/505a3be7-26b2-4f80-b968-7612e398f755-upicture4.png
Figure 7: 2-(3-((2-hydroxynaphthalen-1-yl)diazenyl)phenyl)-2-methyl-3-(3-nitrophenyl)-1,3-oxazepane-4,7-dione(L2) and3-(3-((2-hydroxynaphthalen-1-yl)diazenyl)phenyl)-3-methyl-4-(p-tolyl)-3,4-dihydrobenzo[e][1,3]oxazepine-1,5-dione(L6)
https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/ac20e6a6-253e-4c4f-a331-e5a24ebcc78f/image/21a90f05-fff1-4e50-8bed-47add0f42b3e-upicture5.png
Figure 8: 2-(3-((2-hydroxynaphthalen-1-yl)diazenyl)phenyl)-2-methyl-3-(p-tolyl)-1,3-oxazepane-4,7-dione (L3)
https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/ac20e6a6-253e-4c4f-a331-e5a24ebcc78f/image/a5557810-4fd6-43ac-8077-0be10379e33b-upicture6.png
Figure 9: 3-(3-((2-hydroxynaphthalen-1-yl)diazenyl)phenyl)-4-(4-hydroxyphenyl)-3-methyl-3,4-dihydrobenzo[e][1,3]oxazepine-1,5-dione (L4)
https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/ac20e6a6-253e-4c4f-a331-e5a24ebcc78f/image/6a1aba4a-b478-4ff5-b544-e96bb90f25c9-upicture7.png
Figure 10: 1-(3-((2-hydroxynaphthalen-1-yl)diazenyl)phenyl) ethan-1-one (A) and 1-((3-(1-((4-hydroxyphenyl)imino)ethyl)phenyl)diazenyl)naphthalen-2-ol(S1)
https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/ac20e6a6-253e-4c4f-a331-e5a24ebcc78f/image/cc351579-c1d1-4d5b-97c6-b156a2c38c66-upicture8.png
Figure 11: 1-((3-(1-((3-nitrophenyl)imino)ethyl)phenyl)diazenyl)naphthalen-2-ol(S2) and 2-(3-((2-hydroxynaphthalen-1-yl)diazenyl)phenyl)-2-methyl-3-(p-tolyl)-1,3-oxazepane-4,7-dione(L3)
https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/ac20e6a6-253e-4c4f-a331-e5a24ebcc78f/image/64d09f4e-fb2a-4d64-a663-e663e6806f04-upicture9.png
Figure 12: 1-((3-(1-(p-tolylimino)ethyl)phenyl)diazenyl)naphthalen-2-ol(S3) and 3-(3-((2-hydroxynaphthalen-1-yl)diazenyl)phenyl)-4-(4-hydroxyphenyl)-3-methyl-3,4-dihydrobenzo[e][1,3]oxazepine-1,5-dione (L4)
https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/ac20e6a6-253e-4c4f-a331-e5a24ebcc78f/image/a296cd08-2ae3-4351-b825-4238ab873bee-upicture10.png
Figure 13: 2-(3-((2-hydroxynaphthalen-1-yl)diazenyl)phenyl)-3-(4-hydroxyphenyl)-2-methyl-1,3-oxazepane-4,7-dione(L1) and 3-(3-((2-hydroxynaphthalen-1-yl)diazenyl)phenyl)-3-methyl-4-(3-nitrophenyl)-3,4-dihydrobenzo[e][1,3]oxazepine-1,5-dione (L5)
https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/ac20e6a6-253e-4c4f-a331-e5a24ebcc78f/image/3763af8a-2a4b-4bfe-8e83-144b7c391c83-upicture11.png
Figure 14: 2-(3-((2-hydroxynaphthalen-1-yl)diazenyl)phenyl)-2-methyl-3-(3-nitrophenyl)-1,3-oxazepane-4,7-dione(L2) and3-(3-((2-hydroxynaphthalen-1-yl)diazenyl)phenyl)-3-methyl-4-(p-tolyl)-3,4-dihydrobenzo[e][1,3]oxazepine-1,5-dione(L6)
https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/ac20e6a6-253e-4c4f-a331-e5a24ebcc78f/image/9e16d952-324d-4d44-b4f3-f8c75a99973a-upicture12.png
Figure 15: 1-(3-((2-hydroxynaphthalen-1-yl)diazenyl)phenyl) ethan-1-one (A) and 1-((3-(1-((4-hydroxyphenyl)imino)ethyl)phenyl)diazenyl)naphthalen-2-ol(S1)
https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/ac20e6a6-253e-4c4f-a331-e5a24ebcc78f/image/3f296bbf-3a18-4cd5-8b29-5d236371e183-upicture13.png
Figure 16: 1-((3-(1-((3-nitrophenyl)imino)ethyl)phenyl)diazenyl)naphthalen-2-ol(S2) and 1-((3-(1-(p-tolylimino)ethyl)phenyl)diazenyl)naphthalen-2-ol (S3)
https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/ac20e6a6-253e-4c4f-a331-e5a24ebcc78f/image/8c4df2d8-cc23-40bf-b494-ec5ef40d97f6-upicture14.png
Figure 17: 2-(3-((2-hydroxynaphthalen-1-yl)diazenyl)phenyl)-3-(4-hydroxyphenyl)-2-methyl-1,3-oxazepane-4,7-dione(L1) and3-(3-((2-hydroxynaphthalen-1-yl)diazenyl)phenyl)-3-methyl-4-(3-nitrophenyl)-3,4-dihydrobenzo[e][1,3]oxazepine-1,5-dione (L5)
https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/ac20e6a6-253e-4c4f-a331-e5a24ebcc78f/image/56a07289-85fc-4023-9ac7-6e12f3bf69e0-upicture15.png
Figure 18: 2-(3-((2-hydroxynaphthalen-1-yl)diazenyl)phenyl)-2-methyl-3-(3-nitrophenyl)-1,3-oxazepane-4,7-dione(L2) and3-(3-((2-hydroxynaphthalen-1-yl)diazenyl)phenyl)-3-methyl-4-(p-tolyl)-3,4-dihydrobenzo[e][1,3]oxazepine-1,5-dione(L6)
https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/ac20e6a6-253e-4c4f-a331-e5a24ebcc78f/image/deb46fec-b423-4737-9fe5-943160001a53-upicture16.png
Figure 19: 2-(3-((2-hydroxynaphthalen-1-yl)diazenyl)phenyl)-2-methyl-3-(p-tolyl)-1,3-oxazepane-4,7-dione(L3)
https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/ac20e6a6-253e-4c4f-a331-e5a24ebcc78f/image/ed31eb91-ae4a-4255-8e91-4b4f9ac06810-upicture17.png
Figure 20: 3-(3-((2-hydroxynaphthalen-1-yl)diazenyl)phenyl)-4-(4-hydroxyphenyl)-3-methyl-3,4-dihydrobenzo[e][1,3]oxazepine-1,5-dione (L4)

1 HNMR- Spectra of derivatives

Using DMSO as a solvent, 1HNMR- Spectra of derivatives are shown in Figure 14; Figure 13; Figure 12; Figure 11; Figure 10.

A

S1Singlet 2.077ppm(CH3), 2.512 ppm(Dmso), multipleting singal at 6.998-7.643 ppm (phenal ring), 10.743-11-381 ppm (OH).

S2Singlet 2.064ppm(CH3), singlet 2.515ppm (Dmso), multipleting singal at 7.038-7.980 ppm (phenal ring),11.814 ppm (OH).

S3Singlet 1.718ppm-2.088ppm (CH3) , singlet 2.518ppm (Dmso) , multipleting singal at 7.401-8.498 ppm (phenal ring ) , single 11.518ppm (OH).

L1Singlet 2.018ppm (CH3), singlet 2.524 ppm (Dmso),doublet singnal at 6.849-6. 23ppm (CH=CH), multipleting signal at 7.536-8.392ppm(phenal ring) , singlet 10.818- 11.497ppm(OH).

L2 Singlet 2.097ppm (CH3),singlet 2.523 ppm (Dmso),doublet singnal at 6.6-6.8ppm (CH=CH),multipleting signal at 7.717-8.159ppm(phenal ring), singlet 11.797ppm(OH).

L3 Singlet 1.813-2.113ppm (CH3),singlet 2.522 ppm (Dmso),doublet singnal at 6.483-6.493ppm (CH=CH),multipleting signal at 7.152 – 7.376ppm(phenal ring), singlet 11.028ppm(OH).

L4Singlet 2.019ppm(CH3), singlet 2.520 ppm (Dmso), multipleting signal 6.8 – 7.8ppm(phenal ring), 10.135- 11.435ppm(OH).

L5 Singlet 2.053ppm(CH3), singlet 2.520 ppm (Dmso), multipleting signal 7.036 – 7.932 ppm(phenal ring), 11.728 ppm(OH).

L6 Singlet 1.534 - 2.084ppm(CH3, singlet 2.523 ppm (Dmso), multipleting signal 7.6-8.2 ppm(phenal ring), 11.584 ppm(OH).

The C13.NMR Spectral of derivatives

Using DMSO as a Solvent, the C13.NMR Spectrums of derivatives are shown in Figure 20; Figure 19; Figure 18; Figure 17; Figure 16; Figure 15.

A

S1Singlet273ppm(CH3), 159PPM (C=N),153-154 ppm (OH).

S2Singlet 26.411(CH3), 159.054PPM(C=N),154 ppm (OH).

S3Singlet 21.605-25605 (CH3), 159.432PPM, single153.442PPM (OH).

L1Singlet 27.57PPM (CH3),160.7PPM (O-C-N), 172.57 – 174.4 PPM (C=O), 163.7 PPM (HC=CH), 153.6-154.8ppm(OH).

L2 Singlet 25.63PPM (CH3),161.12PPM (O-C-N),172.77-173.56ppm(C=O) ,164.12PPM(HC=CH), 155.057ppm(OH).

L

L4Singlet26.46ppm(CH3),160.2PPM(O-C-N),174.6-175.1PPM(C=O),153.1-154.1ppm(OH).

L5Singlet 26.5ppm(CH3),160.7PPM(O-C-N),172.4-173.9PPM(C=O),154.6ppm(OH).

L6Singlet26.6-22.2ppm(CH3),163PPM(O-C-N),171-175PPM(C=O),154.2ppm(OH).

Conclusion

This study presents a synthesis of innovative oxazepine derivatives by multi-reaction steps. The initial step synthesis azo derivative from 2-naphthol with 3-aminoacetophenone. The second step has been the condensation reacting between ketone group of the azo compound and diverse primary aromatic amines (4-amino phenol, 3-nitro aniline and 4-methyl aniline) to yiled new azo Schiff base compounds (S1-S3) respectively. In the last step, Oxazepine compounds (L1-L3)and (L4-L6) have been organized by reacting imine compounds (S1-S3) with maleic and phthalic anhydride in toluene as solvent. All these derivatives have categorized by melting point, FTIR, HNMR and 13CNMR.